A&D Pharma remains on the rise

A&D Pharma, the biggest pharmaceutical group on the Romanian market, recorded its best performance this year in the third quarter, with its turnover rising 35.9% to 179 million euros.
“Our wholesale division Mediplus continues to see a rapid development (…), while Sensiblu, the biggest drugstore chain under one brand in Romania, records significant sales rises. The marketing & sales activity has started to integrate recently acquired activities in five neighbouring countries,” says Robert Popescu, CEO of A&D Pharma.
Part of the company’s growth comes from integrating the international business, which generated 16.7 million euros in the July-September period of 2010.
A&D Pharma stock has been trading on the main market of the London Stock Exchange since October 2006. The latest transactions were conducted at a price of 5.7 euros per GDR, which puts the capitalisation at nearly 190 million euros.
A&D Pharma is indirectly controlled by businessmen Walid Abboud, Ludovic Robert, Roger Akoury and Michel Eid.